Cyberonics' Ambitious 5-Year Plan: Double Sales With New VNS Components
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics aims to double its sales to $320 million over the next five years by improving and adding new features to its VNS Therapy vagus nerve stimulation implant and entering new markets like Japan